Customize
Quick Links

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgement of Commercial Support

This activity is supported by educational an educational grant from Merck Sharp & Dohme Corp.

About
Accreditation
Privacy Policy
Terms & Conditions
Executive Board
Journal
Faculty Portal
Contact
Facebook
Twitter
LinkedIn
Google +
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 1-609-378-3701

Copyright © 2019
Physicians’ Education Resource ®, LLC.
All rights reserved.

SGO: Evolutions in the Treatment and Management of Advanced Cervical Cancer: Leveraging the Immunosuppressive Microenvironment, Addressing Ongoing Clinical Needs

SGO: Evolutions in the Treatment and Management of Advanced Cervical Cancer: Leveraging the Immunosuppressive Microenvironment, Addressing Ongoing Clinical Needs


Saturday, March 16, 2019
11:00 AM - 12:30 PM

Hawaii Convention Center
1801 Kalakaua Avenue
Honolulu, HI 96815

Overview:

Although cervical cancer is highly treatable and associated with high rates of positive clinical outcomes when detected early enough, many cases are not detected until they have reached an advanced stage. The management of patients with advanced/metastatic disease remains an important clinical challenge. Pursuit of treatment options that may help to improve clinical efficacy and limit treatment-associated adverse events is an active area of investigation, with several options showing promise in recent studies. The understanding of the mechanisms underlying the development of cervical cancer has helped to inform new approaches to its treatment, which may improve outcomes for your patients. Keeping up with these advancements can be a challenging goal for busy clinicians, as can development of a thorough understanding of potential applications of new data from trials evaluating therapeutic approaches for advanced cervical cancer.

In order to help you meet these goals, this live activity will feature the perspectives of leading experts in the field of cervical cancer, who will explore recent clinical developments through didactic presentation, case-based discussion, and panel interaction with the audience. The faculty will cover a wide range of topics, including the current landscape of treatment options for patients with cervical cancer, recent advancements in the understanding of the tumor microenvironment and how this influences immune response, the evolving role of immunotherapeutics for cervical cancer, and emerging biomarkers that may govern treatment selection for your patients.

Acknowledgement of Commercial Support

This activity is supported by educational an educational grant from Merck Sharp & Dohme Corp.

Target Audience

This educational program is directed toward medical oncologists, gynecologic oncologists, pathologists, radiation oncologists, and surgical oncologists involved in the treatment and management of cervical cancer. Obstetrician/gynecologists, nurses, physician assistants, fellows, residents, and other healthcare professionals with an interest in cervical cancer will also be invited to participate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

  • Describe the rationale underlying the use of immunotherapy strategies for the management of cervical cancer
  • Assess emerging efficacy and safety data on immunotherapy, including application to evolving treatment paradigms for patients with locally advanced, unresectable, and metastatic forms of cervical cancer
  • Discuss evolving uses for biomarkers to practically inform clinical decision-making concerning treatment strategies to manage cervical cancer
  • Apply practical case-based strategies across multidisciplinary teams to optimize outcomes among patients with cervical cancer in multiple lines of therapy

Program Chair

Bradley J. Monk, MD, FACS, FACOG
Professor
Division of Gynecologic Oncology
Arizona Oncology (US Oncology Network)
University of Arizona College of Medicine
Phoenix Creighton University School of Medicine at St. Joseph's Hospital
Medical Director
US Oncology Research Network - Gynecologic Program
Phoenix, AZ







Become a Member

Forgot Password?
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
     12
3456789
10111213141516
17181920212223
2425262728
Filter By